Yersinia enterocolitica: Subversion of adaptive immunity and implications for vaccine development

International Journal of Medical Microbiology

Volumn 298, Issue 1-2, 2008, Pages 69-77

  Autenrieth, Stella E ^a   Autenrieth, Ingo B ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Carrier; Dendritic cells; Invasin; Vaccine; Yersinia

Indexed keywords

B7 ANTIGEN; BACTERIAL ANTIGEN; BETA1 INTEGRIN; CD11B ANTIGEN; CD18 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 8; INVASIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR ALPHA; VACCINE; VIRULENCE FACTOR; YERSINIA OUTER PROTEIN E;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; BACTERIAL STRAIN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; HOST CELL; INNATE IMMUNITY; LYMPHOID TISSUE; MUCOSAL IMMUNITY; NONHUMAN; PEYER PATCH; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; VACCINATION; YERSINIA ENTEROCOLITICA;

EID: 36749103892     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2007.07.010     Document Type: Short Survey

References (83)

1. Alrutz M.A., and Isberg R.R. Involvement of focal adhesion kinase in invasin-mediated uptake. Proc. Natl. Acad. Sci. USA 95 (1998) 13658-13663
2. Alrutz M.A., Srivastava A., Wong K.W., Souza-Schorey C., Tang M., Ch'Ng L.E., Snapper S.B., and Isberg R.R. Efficient uptake of Yersinia pseudotuberculosis via integrin receptors involves a Rac1-Arp 2/3 pathway that bypasses N-WASP function. Mol. Microbiol. 42 (2001) 689-703
3. Andor A., Trülzsch K., Essler M., Roggenkamp A., Wiedemann A., Heesemann J., and Aepfelbacher M. YopE of Yersinia, a GAP for Rho GTPases, selectively modulates Rac-dependent actin structures in endothelial cells. Cell. Microbiol. 3 (2001) 301-310
4. Arencibia I., Frankel G., and Sundqvist K.G. Induction of cell death in T lymphocytes by invasin via beta1-integrin. Eur. J. Immunol. 32 (2002) 1129-1138
5. Autenrieth I.B., and Firsching R. Penetration of M cells and destruction of Peyer's patches by Yersinia enterocolitica: an ultrastructural and histological study. J. Med. Microbiol. 44 (1996) 285-294
6. Autenrieth I.B., and Schmidt M.A. Bacterial interplay at intestinal mucosal surfaces: implications for vaccine development. Trends Microbiol. 8 (2000) 457-464
7. Autenrieth I.B., Tingle A., Reske-Kunz A., and Heesemann J. T lymphocytes mediate protection against Yersinia enterocolitica in mice: characterization of murine T-cell clones specific for Y. enterocolitica. Infect. Immun. 60 (1992) 1140-1149
8. Autenrieth I.B., Vogel U., Preger S., Heymer B., and Heesemann J. Experimental Yersinia enterocolitica infection in euthymic and T-cell-deficient athymic nude C57BL/6 mice: comparison of time course, histomorphology, and immune response. Infect. Immun. 61 (1993) 2585-2595
9. Autenrieth I.B., Kempf V., Sprinz T., Preger S., and Schnell A. Defense mechanisms in Peyer's patches and mesenteric lymph nodes against Yersinia enterocolitica involve integrins and cytokines. Infect. Immun. 64 (1996) 1357-1368
10. Autenrieth S.E., Soldanova I., Rosemann R., Gunst D., Zahir N., Kracht M., Ruckdeschel K., Wagner H., Borgmann S., and Autenrieth I.B. Yersinia enterocolitica YopP inhibits MAP kinase-mediated antigen uptake in dendritic cells. Cell. Microbiol. 9 (2007) 425-437
11. Barz C., Abahji T.N., Trülzsch K., and Heesemann J. The Yersinia Ser/Thr protein kinase YpkA/YopO directly interacts with the small GTPases RhoA and Rac-1. FEBS Lett. 482 (2000) 139-143
12. Black D.S., and Bliska J.B. Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions. EMBO J. 16 (1997) 2730-2744
13. Black D.S., and Bliska J.B. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Mol. Microbiol. 37 (2000) 515-527
14. Blander J.M., and Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440 (2006) 808-812
15. Bohn E., and Autenrieth I.B. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells. J. Immunol. 156 (1996) 1458-1468
16. Boland A., and Cornelis G.R. Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection. Infect. Immun. 66 (1998) 1878-1884
17. Brett S.J., Mazurov A.V., Charles I.G., and Tite J.P. The invasin protein of Yersinia spp. provides co-stimulatory activity to human T cells through interaction with beta 1 integrins. Eur. J. Immunol. 23 (1993) 1608-1614
18. Buhler O.T., Wiedig C.A., Schmid Y., Grassl G.A., Bohn E., and Autenrieth I.B. The Yersinia enterocolitica invasin protein promotes major histocompatibility complex class I- and class II-restricted T-cell responses. Infect. Immun. 74 (2006) 4322-4329
19. Cornelis G.R. Molecular and cell biology aspects of plague. Proc. Natl. Acad. Sci. USA 97 (2000) 8778-8783
20. Cornelis G.R. Yersinia type III secretion: send in the effectors. J. Cell Biol. 158 (2002) 401-408
21. Corthesy-Theulaz I.E., Hopkins S., Bachmann D., Saldinger P.F., Porta N., Haas R., Zheng-Xin Y., Meyer T., Bouzourene H., Blum A.L., and Kraehenbuhl J.P. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits. Infect. Immun. 66 (1998) 581-586
22. Cover T.L., and Aber R.C. Yersinia enterocolitica. N. Engl. J. Med. 321 (1989) 16-24
23. Critchley-Thorne R.J., Stagg A.J., and Vassaux G. Recombinant Escherichia coli expressing invasin targets the Peyer's patches: the basis for a bacterial formulation for oral vaccination. Mol. Ther. 14 (2006) 183-191
24. Cuadros C., Lopez-Hernandez F.J., Dominguez A.L., McClelland M., and Lustgarten J. Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses. Infect. Immun. 72 (2004) 2810-2816
25. Denecker G., Declercq W., Geuijen C.A., Boland A., Benabdillah R., van G.M., Sory M.P., Vandenabeele P., and Cornelis G.R. Yersinia enterocolitica YopP-induced apoptosis of macrophages involves the apoptotic signaling cascade upstream of bid. J. Biol. Chem. 276 (2001) 19706-19714
26. Dersch P., and Isberg R.R. A region of the Yersinia pseudotuberculosis invasin protein enhances integrin-mediated uptake into mammalian cells and promotes self-association. EMBO J. 18 (1999) 1199-1213
27. Di Genaro M.S., Waidmann M., Kramer U., Hitziger N., Bohn E., and Autenrieth I.B. Attenuated Yersinia enterocolitica mutant strains exhibit differential virulence in cytokine-deficient mice: implications for the development of novel live carrier vaccines. Infect. Immun. 71 (2003) 1804-1812
28. Eldridge J.H., Staas J.K., Meulbroek J.A., Tice T.R., and Gilley R.M. Biodegradable and biocompatible poly(dl-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect. Immun. 59 (1991) 2978-2986
29. Erfurth S.E., Grobner S., Kramer U., Gunst D.S., Soldanova I., Schaller M., Autenrieth I.B., and Borgmann S. Yersinia enterocolitica induces apoptosis and inhibits surface molecule expression and cytokine production in murine dendritic cells. Infect. Immun. 72 (2004) 7045-7054
30. Everest P., Griffiths P., and Dougan G. Live Salmonella vaccines as a route towards oral immunisation. Biologicals 23 (1995) 119-124
31. Feldman M.F., Muller S., Wuest E., and Cornelis G.R. SycE allows secretion of YopE-DHFR hybrids by the Yersinia enterocolitica type III Ysc system. Mol. Microbiol. 46 (2002) 1183-1197
32. Galyov E.E., Hakansson S., and Wolf-Watz H. Characterization of the operon encoding the YpkA Ser/Thr protein kinase and the YopJ protein of Yersinia pseudotuberculosis. J. Bacteriol. 176 (1994) 4543-4548
33. Grassl G.A., Kracht M., Wiedemann A., Hoffmann E., Aepfelbacher M., von Eichel-Streiber C., Bohn E., and Autenrieth I.B. Activation of NF-kappaB and IL-8 by Yersinia enterocolitica invasin protein is conferred by engagement of Rac1 and MAP kinase cascades. Cell. Microbiol. 5 (2003) 957-971
34. Grobner S., Autenrieth S.E., Soldanova I., Gunst D.S., Schaller M., Bohn E., Muller S., Leverkus M., Wesselborg S., Autenrieth I.B., and Borgmann S. Yersinia YopP-induced apoptotic cell death in murine dendritic cells is partially independent from action of caspases and exhibits necrosis-like features. Apoptosis 11 (2006) 1959-1968
35. Grutzkau A., Hanski C., Hahn H., and Riecken E.O. Involvement of M cells in the bacterial invasion of Peyer's patches: a common mechanism shared by Yersinia enterocolitica and other enteroinvasive bacteria. Gut 31 (1990) 1011-1015
36. Gundel I., Weidinger G., ter Meulen V., Heesemann J., Rüssmann H., and Niewiesk S. Oral immunization with recombinant Yersinia enterocolitica expressing a measles virus CD4 T cell epitope protects against measles virus-induced encephalitis. J. Gen. Virol. 84 (2003) 775-779
37. Hanski C., Kutschka U., Schmoranzer H.P., Naumann M., Stallmach A., Hahn H., Menge H., and Riecken E.O. Immunohistochemical and electron microscopic study of interaction of Yersinia enterocolitica serotype O8 with intestinal mucosa during experimental enteritis. Infect. Immun. 57 (1989) 673-678
38. Honko A.N., Sriranganathan N., Lees C.J., and Mizel S.B. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis. Infect. Immun. 74 (2006) 1113-1120
39. Igwe E.I., Rüssmann H., Roggenkamp A., Noll A., Autenrieth I.B., and Heesemann J. Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocolitica. Infect. Immun. 67 (1999) 5500-5507
40. Iriarte M., and Cornelis G.R. YopT, a new Yersinia Yop effector protein, affects the cytoskeleton of host cells. Mol. Microbiol. 29 (1998) 915-929
41. Isberg R.R., and Leong J.M. Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 60 (1990) 861-871
42. Jacobi C.A., Roggenkamp A., Rakin A., Zumbihl R., Leitritz L., and Heesemann J. In vitro and in vivo expression studies of yopE from Yersinia enterocolitica using the gfp reporter gene. Mol. Microbiol. 30 (1998) 865-882
43. Kerksiek K.M., Niedergang F., Chavrier P., Busch D.H., and Brocker T. Selective Rac1 inhibition in dendritic cells diminishes apoptotic cell uptake and cross-presentation in vivo. Blood 105 (2005) 742-749
44. Kerschen E.J., Cohen D.A., Kaplan A.M., and Straley S.C. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect. Immun. 72 (2004) 4589-4602
45. Kovacsovics-Bankowski M., Clark K., Benacerraf B., and Rock K.L. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA 90 (1993) 4942-4946
46. Leong J.M., Fournier R.S., and Isberg R.R. Identification of the integrin binding domain of the Yersinia pseudotuberculosis invasin protein. EMBO J. 9 (1990) 1979-1989
47. Leong J.M., Morrissey P.E., Marra A., and Isberg R.R. An aspartate residue of the Yersinia pseudotuberculosis invasin protein that is critical for integrin binding. EMBO J. 14 (1995) 422-431
48. Lloyd S.A., Forsberg A., Wolf-Watz H., and Francis M.S. Targeting exported substrates to the Yersinia TTSS: different functions for different signals?. Trends Microbiol. 9 (2001) 367-371
49. Lloyd S.A., Norman M., Rosqvist R., and Wolf-Watz H. Yersinia YopE is targeted for type III secretion by N-terminal, not mRNA, signals. Mol. Microbiol. 39 (2001) 520-531
50. Maloy K.J., Donachie A.M., O'Hagan D.T., and Mowat A.M. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Immunology 81 (1994) 661-667
51. Medina E., and Guzman C.A. Use of live bacterial vaccine vectors for antigen delivery: potential and limitations. Vaccine 19 (2001) 1573-1580
52. Monack D.M., Mecsas J., Bouley D., and Falkow S. Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice. J. Exp. Med. 188 (1998) 2127-2137
53. Muno D., Kominami E., and Mizuochi T. Generation of both MHC class I- and class II-restricted antigenic peptides from exogenously added ovalbumin in murine phagosomes. FEBS Lett. 478 (2000) 178-182
54. Nixon D.F., Hioe C., Chen P.D., Bian Z., Kuebler P., Li M.L., Qiu H., Li X.M., Singh M., Richardson J., McGee P., Zamb T., Koff W., Wang C.Y., and O'Hagan D. Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity. Vaccine 14 (1996) 1523-1530
55. O'Hagan D.T., Jeffery H., Roberts M.J., McGee J.P., and Davis S.S. Controlled release microparticles for vaccine development. Vaccine 9 (1991) 768-771
56. Orth K., Palmer L.E., Bao Z.Q., Stewart S., Rudolph A.E., Bliska J.B., and Dixon J.E. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science 285 (1999) 1920-1923
57. Palmer L.E., Hobbie S., Galan J.E., and Bliska J.B. YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-alpha production and downregulation of the MAP kinases p38 and JNK. Mol. Microbiol. 27 (1998) 953-965
58. Pashine A., Valiante N.M., and Ulmer J.B. Targeting the innate immune response with improved vaccine adjuvants. Nat. Med. 11 (2005) S63-S68
59. Persson C., Carballeira N., Wolf-Watz H., and Fallman M. The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions. EMBO J. 16 (1997) 2307-2318
60. Rankin S., Isberg R.R., and Leong J.M. The integrin-binding domain of invasin is sufficient to allow bacterial entry into mammalian cells. Infect. Immun. 60 (1992) 3909-3912
61. Rosqvist R., Forsberg A., and Wolf-Watz H. Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption. Infect. Immun. 59 (1991) 4562-4569
62. Ruckdeschel K., and Richter K. Lipopolysaccharide desensitization of macrophages provides protection against Yersinia enterocolitica-induced apoptosis. Infect. Immun. 70 (2002) 5259-5264
63. Ruckdeschel K., Roggenkamp A., Lafont V., Mangeat P., Heesemann J., and Rouot B. Interaction of Yersinia enterocolitica with macrophages leads to macrophage cell death through apoptosis. Infect. Immun. 65 (1997) 4813-4821
64. Ruckdeschel K., Harb S., Roggenkamp A., Hornef M., Zumbihl R., Kohler S., Heesemann J., and Rouot B. Yersinia enterocolitica impairs activation of transcription factor NF-kappaB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor alpha production. J. Exp. Med. 187 (1998) 1069-1079
65. Ruckdeschel K., Richter K., Mannel O., and Heesemann J. Arginine-143 of Yersinia enterocolitica YopP crucially determines isotype-related NF-kappaB suppression and apoptosis induction in macrophages. Infect. Immun. 69 (2001) 7652-7662
66. Rüssmann H., Weissmuller A., Geginat G., Igwe E.I., Roggenkamp A., Bubert A., Goebel W., Hof H., and Heesemann J. Yersinia enterocolitica-mediated translocation of defined fusion proteins to the cytosol of mammalian cells results in peptide-specific MHC class I-restricted antigen presentation. Eur. J. Immunol. 30 (2000) 1375-1384
67. Rüssmann H., Gerdemann U., Igwe E.I., Panthel K., Heesemann J., Garbom S., Wolf-Watz H., and Geginat G. Attenuated Yersinia pseudotuberculosis carrier vaccine for simultaneous antigen-specific CD4 and CD8 T-cell induction. Infect. Immun. 71 (2003) 3463-3472
68. Schafer R., Portnoy D.A., Brassell S.A., and Paterson Y. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine. J. Immunol. 149 (1992) 53-59
69. Schesser K., Spiik A.K., Dukuzumuremyi J.M., Neurath M.F., Pettersson S., and Wolf-Watz H. The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Mol. Microbiol. 28 (1998) 1067-1079
70. Schlecht G., Loucka J., Najar H., Sebo P., and Leclerc C. Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming. J. Immunol. 173 (2004) 6089-6097
71. Schoppet M., Bubert A., and Huppertz H.I. Dendritic cell function is perturbed by Yersinia enterocolitica infection in vitro. Clin. Exp. Immunol. 122 (2000) 316-323
72. Schulte R., Grassl G.A., Preger S., Fessele S., Jacobi C.A., Schaller M., Nelson P.J., and Autenrieth I.B. Yersinia enterocolitica invasin protein triggers IL-8 production in epithelial cells via activation of Rel p65-p65 homodimers. FASEB J. 14 (2000) 1471-1484
73. Schulte R., Kerneis S., Klinke S., Bartels H., Preger S., Kraehenbuhl J.P., Pringault E., and Autenrieth I.B. Translocation of Yersinia entrocolitica across reconstituted intestinal epithelial monolayers is triggered by Yersinia invasin binding to beta1 integrins apically expressed on M-like cells. Cell. Microbiol. 2 (2000) 173-185
74. Shao F., Vacratsis P.O., Bao Z., Bowers K.E., Fierke C.A., and Dixon J.E. Biochemical characterization of the Yersinia YopT protease: cleavage site and recognition elements in Rho GTPases. Proc. Natl. Acad. Sci. USA 100 (2003) 904-909
75. Sirard J.C., Niedergang F., and Kraehenbuhl J.P. Live attenuated Salmonella: a paradigm of mucosal vaccines. Immunol. Rev. 171 (1999) 5-26
76. Sory M.P., Hermand P., Vaerman J.P., and Cornelis G.R. Oral immunization of mice with a live recombinant Yersinia enterocolitica O:9 strain that produces the cholera toxin B subunit. Infect. Immun. 58 (1990) 2420-2428
77. Suzuki T., Yoshikawa Y., Ashida H., Iwai H., Toyotome T., Matsui H., and Sasakawa C. High vaccine efficacy against shigellosis of recombinant noninvasive Shigella mutant that expresses Yersinia invasin. J. Immunol. 177 (2006) 4709-4717
78. Trülzsch K., Sporleder T., Igwe E.I., Rüssmann H., and Heesemann J. Contribution of the major secreted yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model. Infect. Immun. 72 (2004) 5227-5234
79. Trülzsch K., Geginat G., Sporleder T., Ruckdeschel K., Hoffmann R., Heesemann J., and Rüssmann H. Yersinia outer protein P inhibits CD8 T cell priming in the mouse infection model. J. Immunol. 174 (2005) 4244-4251
80. Westwood A., Elvin S.J., Healey G.D., Williamson E.D., and Eyles J.E. Immunological responses after immunisation of mice with microparticles containing antigen and single stranded RNA (polyuridylic acid). Vaccine 24 (2006) 1736-1743
81. Wiedemann A., Linder S., Grassl G., Albert M., Autenrieth I., and Aepfelbacher M. Yersinia enterocolitica invasin triggers phagocytosis via beta1 integrins, CDC42Hs and WASp in macrophages. Cell. Microbiol. 3 (2001) 693-702
82. Wiedig C.A., Kramer U., Garbom S., Wolf-Watz H., and Autenrieth I.B. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains. Vaccine 23 (2005) 4984-4998
83. Zumbihl R., Aepfelbacher M., Andor A., Jacobi C.A., Ruckdeschel K., Rouot B., and Heesemann J. The cytotoxin YopT of Yersinia enterocolitica induces modification and cellular redistribution of the small GTP-binding protein RhoA. J. Biol. Chem. 274 (1999) 29289-29293